View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
April 15, 2019

UK researchers to develop new digital gait-monitoring technology

A research team at the University of Sheffield has secured funding to develop a monitoring system to assess a patient's health and wellbeing based on their gait.

A research team at the University of Sheffield has secured funding to develop a monitoring system to assess a patient’s health and wellbeing based on their gait.

Comprising an array of small sensors, the technology is expected to be used to observe the effects of diseases such as Parkinson’s, chronic obstructive pulmonary disease (COPD), multiple sclerosis, proximal femoral fracture and congestive heart failure.

Poor gait is also linked to cognitive decline, dementia, higher risk of falls, greater disease risk and earlier death.

The €2.1m grant will be provided by the European Innovative Medicines Initiative 2 Joint Undertaking.

“MOBILISE-D is the product of a long-standing multidisciplinary collaboration between researchers at the Insigneo Institute for in silico Medicine and the NIHR Sheffield Biomedical Research Centre.”

The research forms part of the European MOBILISE-D project, which aims to use digital technology to assess mobility loss while facilitating improved clinical trials and management.

Under the project, clinicians and scientists from academic centres in Europe will work with European Federation of Pharmaceutical Industries and Associations (EFPIA) member companies.

A total of 34 organisations are participating in the research, including the Insigneo Institute, which is led by the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust.

The Insigneo Institute director and the university’s department of mechanical engineering professor Claudia Mazzà will lead the development of the digital monitoring technology.

Mazzà said: “MOBILISE-D is the product of a long-standing multidisciplinary collaboration between researchers at the Insigneo Institute for in silico Medicine and the NIHR Sheffield Biomedical Research Centre.

“It marks a fantastic opportunity for the University of Sheffield and Sheffield Teaching Hospital to contribute to a technology-based revolution in clinical management and personalised healthcare, with a local focus on multiple sclerosis.”

Sheffield Teaching Hospitals professor Basil Sharrack is set to lead the clinical validation of the technology in multiple sclerosis.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network